What is Brightside Scientific?
Brightside Scientific operates as a premier, ISO/IEC 17025:2017 accredited cannabis testing laboratory, providing critical infrastructure for the medical and recreational sectors. The company specializes in a comprehensive suite of analytical services, including cannabinoid potency profiling, heavy metal screening, and microbiological contaminant detection. By maintaining high-fidelity testing protocols, Brightside Scientific serves as a vital gatekeeper for product safety and regulatory compliance, ensuring that manufacturers meet the stringent requirements mandated by California state authorities. Their technical expertise and established operational framework distinguish them as a high-authority entity in the analytical testing space.
How much funding has Brightside Scientific raised?
Brightside Scientific has raised a total of $62K across 1 funding round:
Debt
$62K
Debt (2021): $62K with participation from PPP
Key Investors in Brightside Scientific
PPP
Public-Private Partnership
What's next for Brightside Scientific?
With the recent influx of capital, Brightside Scientific is poised to accelerate its strategic growth initiatives. The firm is expected to focus on expanding its laboratory capacity to meet the rising demand for standardized testing services as the regulatory environment matures. Future efforts will likely center on technological upgrades to enhance throughput and the integration of advanced diagnostic methodologies. By solidifying its market position through this Series B/C stage financing, the company is prepared to navigate the complexities of the cannabis industry while maintaining its reputation for precision and reliability in quality assurance.
See full Brightside Scientific company page
